Why I did not Change my Car and what this has to do with PE changing Life Sciences

5 min read

Watercolor, minimalistic image of a single, vibrant green sprout growing through a crack in a stark, concrete landscape.

Explore how a personal decision against a new car mirrors Private Equity’s strategic shifts in Life Sciences, driving innovation and efficiency in 2024 “Why not keep it for another year?” the car dealer asked, his voice a mix of curiosity and disbelief. “The new model has everything you could want.” I paused, considering the layers beneath my hesitation. “It’s not just about the car,” I replied. At that moment, my reasons crystallized, each reflecting broader market shifts: COVID-19 had turned my daily commute into a short walk to the home office, casting doubt on the necessity of a new lease. The…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Flavio Aliberti Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.